CIMAGLERMIN ALFA
UNII B2A4EZ9I83

Substance Identification & Data

This profile provides standardized clinical and technical data for Cimaglermin Alfa, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B2A4EZ9I83.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1350717-96-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
B2A4EZ9I83
CAS Registry Number
1350717-96-2
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
CIMAGLERMIN ALFA
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C171891
National Cancer Institute reference terminology for clinical and research data.
INN ID
9890
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
ZZ-94
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cimaglermin Alfa. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CIMAGLERMIN ALFA

Common Names & Synonyms

CIMAGLERMIN ALFA [INN]
CIMAGLERMIN ALFA [USAN]
CIMAGLERMIN ALFA [WHO-DD]
RECOMBINANT DNA DERIVED GLIAL GROWTH FACTOR 2(GGF2), PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS (GLYCOFORM ALFA): (253-L-GLUTAMINE(R>Q VARIANT 009307))HUMAN PRO-NEUREGULIN-1 MEMBRANE-BOUND ISOFORM 9 PRECURSOR-(51-422)-PEPTIDE

Technical Codes

RHGGF2
RHGGF-2

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus